DOCSLIB.ORG

Division of Cancer Control and Population Sciences 2005 Overview & Highlights July 2005 DCC-2745 Briefingbook-Inside 8/29/05 3:23 PM Page 1

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Division of Cancer Control and Population Sciences 2005 Overview & Highlights July 2005 DCC-2745 Briefingbook-Inside 8/29/05 3:23 PM Page 1 2475-DCC Brief Book cvr.f 8/29/05 3:46 PM Page 1 Division of Cancer Control and Population Sciences Division of Cancer Control and Population Sciences 2005 Over view & Highlights 2005 Overview and July 2005 Highlights U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute DCC-2745_BriefingBook-Inside 8/29/05 3:23 PM Page 1 Division of Cancer Control and Population Sciences 2005 Overview and Highlights July 2005 DCC-2745_BriefingBook-Inside 8/29/05 3:23 PM Page ii DCC-2745_BriefingBook-Inside 8/29/05 3:23 PM Page 3 Table of Contents FOREWORD ENERGY BALANCE Director’s Biography . 4 Major Initiatives . 78 Division Points of Contact . 5 Partnerships & Collaborations . 80 Tools, Products, & Resources . 82 ABOUT OUR DIVISION Recent Scientific Advances . 84 Leadership at a Glance . 6 Meet the DCCPS Staff . 8 SURVIVORSHIP Cancer Control Framework and Synthesis Rationale . 10 Major Initiatives . 86 Examples of Major Initiatives. 11 Partnerships & Collaborations . 90 DCCPS Supports Principal Investigators . 12 Tools, Products, & Resources . 92 Recent Scientific Advances . 94 RESEARCH GRANTS & CONTRACTS . 14 HEALTH DISPARITIES SURVEILLANCE Major Initiatives . 98 Major Initiatives . 20 Partnerships & Collaborations . 100 Partnerships & Collaborations . 22 Tools, Products, & Resources . 24 DISSEMINATION AND DIFFUSION Recent Scientific Advances . 28 Major Initiatives . 102 Partnerships & Collaborations . 104 MOLECULAR EPIDEMIOLOGY Tools, Products, & Resources . 106 Major Initiatives . 32 Partnerships & Collaborations . 36 VIEWS FROM LEADERSHIP . 108 Tools, Products, & Resources . 38 RECOMMENDED READING . 120 Recent Scientific Advances . 40 QUALITY OF CARE Major Initiatives . 42 Partnerships & Collaborations . 48 Tools, Products, & Resources . 50 Recent Scientific Advances . 52 TOBACCO CONTROL Major Initiatives . 56 Partnerships & Collaborations . 60 Tools, Products, & Resources . 62 Recent Scientific Advances . 64 BEHAVIORAL RESEARCH Major Initiatives . 66 Partnerships & Collaborations . 70 Tools, Products, & Resources . 72 Recent Scientific Advances . 74 Division of Cancer Control and Population Sciences: Overview & Highlights 3 DCC-2745_BriefingBook-Inside 8/29/05 3:23 PM Page 4 Foreword Robert T. Croyle, PhD Director, Division of Cancer Control and Population Sciences Biosketch s NCI’s bridge to public health Robert T. Croyle, PhD, was BRCA2. His research has been Aresearch, practice, and policy, appointed director of DCCPS published widely in professional the Division of Cancer Control and in July 2003. He previously journals of behavioral science, Population Sciences (DCCPS) plays served as the division’s public health, and cancer, and a unique role in reducing the burden associate director for the he has edited two volumes: of cancer in America. DCCPS, an Behavioral Research Program, Mental Representation in extramural division, has the lead leading its development and Health and Illness (1991) and responsibility at NCI for supporting expansion. Before coming to Psychosocial Effects of Screening research in surveillance, epidemiology, NCI in 1998, he was professor for Disease Prevention and health services, behavioral science, of psychology and a member Detection (1995). and cancer survivorship. The division of the Huntsman Cancer also plays a central role within the Dr. Croyle is a member of the Institute at the University of federal government as a source of Academy of Behavioral Utah in Salt Lake City. Prior expertise and evidence on issues Medicine Research, a fellow to that, he was a visiting such as the quality of cancer care, of the Society of Behavioral investigator at the Fred the economic burden of cancer, Medicine, and a recipient of Hutchinson Cancer Research geographic information systems, several awards for his research Center in Seattle, visiting statistical methods, communication and professional service. His assistant professor of science, tobacco control, and the efforts on journal editorial psychology at the University translation of research into practice. boards include being associate of Washington, and assistant As a result, DCCPS is what many editor for Cancer Epidemiology, professor of psychology at have referred to as a “hybrid” division Biomarkers and Prevention, Williams College in —one that funds a large portfolio and consulting editor for Massachusetts. of grants and contracts, but also Health Psychology and the conducts original research to inform Dr. Croyle received his PhD British Journal of Health public health policy. in social psychology from Psychology. Dr. Croyle received Princeton University in 1985, the NIH Merit Award in 1999 The diverse science funded and and graduated Phi Beta Kappa and 2002, and the NIH conducted by DCCPS is characterized with a BA in psychology from Director’s Award in 2000. by the varied and complex expertise the University of Washington and backgrounds of the division’s in 1978. His recent research has scientific staff. Given the focus on examined how individuals cancer control, it comes as no process, evaluate, and respond to cancer risk information, including tests for inherited mutations in BRCA1 and 4 http://cancercontrol.cancer.gov DCC-2745_BriefingBook-Inside 8/29/05 3:23 PM Page 5 “DCCPS is what many As you read this report about the DIVISION POINTS OF CONTACT activities and accomplishments of have referred to as a DCCPS, it is our hope that three ‘hybrid’ division— themes will emerge. First, almost all of the division’s efforts are one that funds a large accomplished through substantive portfolio of grants collaborations with other NIH institutes, DHHS agencies, and non­ and contracts, but governmental organizations. Second, also conducts original careful priority setting, planning, and evaluation ensure that our efforts research to inform complement and capitalize on the efforts of other research funding public health policy.” organizations. Third, our research portfolio reflects the clear pathways surprise that the disciplines of between discovery, development, epidemiology and biostatistics are and delivery so that etiology and Back L-R: well-represented. In addition, surveillance research inform cancer Everett Carpenter, Information Technology DCCPS has made a special effort control interventions that—when Mary Kashanchi, Administrative Resource Center to recruit experts in disciplines such effectively tested, synthesized, and Stacey Vandor, Planning as communication, anthropology, disseminated—reduce the suffering Mark Alexander, Grants Management outcomes research, psychometrics, and death due to cancer. medical genetics, health psychology, Although this report is intended to Front L-R: economics, social work, policy provide our colleagues within DHHS Arline Sanchez, Executive Assistant analysis, geography, and family with a timely overview of the major Augustina Felix, Secretary medicine—all disciplines that have activities of the division, we hope Cynthia Vinson, Dissemination been historically underrepresented that others might also find it a useful at NCI. This reflects an overarching resource for identifying potential philosophy of science that guides areas of interest and collaboration. the division’s planning and priority setting: the belief that scientific progress in the 21st century will depend on the transdisciplinary integration of research methods, models, and levels of analysis. Division of Cancer Control and Population Sciences: Overview & Highlights 5 DCC-2745_BriefingBook-Inside 8/29/05 3:23 PM Page 6 DCCPS Dr. Robert T. Croyle Director DCCPS Office of Cancer Dr. Jon F. Kerner Survivorship Deputy Director for Dr. Julia H. Rowland Research Dissemination Director & Diffusion Behavioral Research Epidemiology & Genetics Program Research Program Dr. Linda Nebeling Dr. Edward Trapido Associate Director Associate Director (Acting) Analytic Epidemiology Applied Cancer Screening Research Branch Research Branch Dr. Mukesh Verma Dr. Helen Meissner Chief Chief (Acting) Basic & Biobehavioral Clinical & Genetic Research Branch Epidemiology Research Dr. Michael Stefanek Branch Chief Dr. Deborah M. Winn Chief Health Communication & Informatics Research Branch Dr. Bradford Hesse Chief (Acting) Health Promotion Research Branch Dr. Louise Mâsse Chief (Acting) Tobacco Control Research Branch Dr. Cathy Backinger Chief (Acting) 6 http://cancercontrol.cancer.gov DCC-2745_BriefingBook-Inside 8/29/05 3:24 PM Page 7 About Our Division LEADERSHIP AT A GLANCE The DCCPS senior leadership team is often described as dedicated and innovative. ABOUT OUR DIVISION We pride ourselves not only in our dedication to cancer control, but also in our willingness to utilize unconventional ideas and approaches to accelerate progress in cancer research. To read DCCPS senior staff members’ Views f r om Leadership, see pages 108-119. Applied Research Surveillance Program Research Program Dr. Rachel Ballard-Barbash Dr. Brenda K. Edwards Associate Director Associate Director Health Services & Cancer Statistics Branch Economics Branch Dr. Benjamin Hankey Dr. Martin Brown Chief Chief Statistical Research Branch Outcomes Research Branch & Applications Dr. Steven Clauser Dr. Eric Feuer Chief Chief Risk Factor Monitoring & Methods Branch Dr. Susan Krebs-Smith Chief Division of Cancer Control and Population Sciences: Overview & Highlights 7 DCC-2745_BriefingBook-Inside 8/29/05 3:24 PM Page 8 Meet the DCCPS Staff CCPS was organized in 1997 to lead NCI’s Analytical Epidemiology Research Branch Defforts in cancer control research. Since Hartmuller,
Load more

Recommended publications
  • Sanofi-Aventis Press Release
    Sanofi-aventis press release Sanofi-aventis appoints Dr. Elias Zerhouni, President, Global Research & Development Paris, France - December 14, 2010 - Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) is pleased to announce the appointment of Dr. Elias Zerhouni as President, Global Research & Development, covering Medicines and Vaccines, effective January 1, 2011. Dr. Zerhouni will report directly to Christopher A. Viehbacher, Chief Executive Officer of sanofi-aventis, and join the Executive Committee and the Management Committee. Marc Cluzel, M.D., Ph.D., will resign as Executive Vice President, R&D but will continue to work closely with Elias as a scientific expert. “I would like to sincerely thank Marc for his long term contribution. His passion for science and commitment thus far has ensured a readiness to lead the implementation of the transformation of R&D over the past few years,” said Christopher A. Viehbacher, Chief Executive Officer of sanofi-aventis. Since his appointment as Scientific Advisor to Christopher Viehbacher in February 2009, Dr. Zerhouni has been instrumental in redesigning the R&D model to foster increased innovation, the first pillar of the Group’s strategy. The effect of this transformation has already delivered results with a reinvigorated R&D that will provide innovative solutions in response to specific, unmet needs of patients. Centered on the patient, the development of scientific networks and openness to the external scientific world has strengthened the creativity and the flexibility of the company and brought a truly entrepreneurial approach to research. “I have had the privilege of working with Elias for a long time. Through his vast experience and visionary approach, he has provided excellent advice and insight and has been central in implementing what is now one of the most promising R&D models in healthcare,” said Christopher A.
    [Show full text]
  • Eulogy for the Clinical Research Center
    Eulogy for the clinical research center David G. Nathan, David M. Nathan J Clin Invest. 2016;126(7):2388-2391. https://doi.org/10.1172/JCI88381. Op-Ed The extramural General Clinical Research Center (GCRC) program has been funded for more than 50 years, first by the National Center for Research Resources, NIH, and more recently as part of the Clinical Translational Science Award (CTSA) program through the newly formed National Center for Advancing Translation Sciences (NCATS). The GCRCs represent the federally funded laboratories that employ a highly trained cadre of research nurses, dietitians, and other support staff and in which generations of clinical investigators trained and performed groundbreaking human studies that advanced medical science and improved clinical care. Without the opportunity for adequate discussion, NCATS has now stopped funding these Research Centers. In this “eulogy,” we review the origins and history of the GCRCs, their contributions to the advancement of medicine, and the recent events that have essentially defunded them. We mourn their loss. Find the latest version: https://jci.me/88381/pdf OP-ED The Journal of Clinical Investigation Eulogy for the clinical research center David G. Nathan1 and David M. Nathan2 1Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. 2Diabetes Center and Clinical Research Center, Massachusetts General Hospital (MGH), Harvard Medical School, Boston, Massachusetts, USA. icans with a desire to learn the biomedical research technology of the early twentieth The extramural General Clinical Research Center (GCRC) program has been century were forced to travel to England, funded for more than 50 years, first by the National Center for Research France, Austria, or Germany.
    [Show full text]
  • TOXMAP: a GIS Information Portal to Environmental Health Databases
    TOXMAP: A GIS Information Portal to Environmental Health Databases Marti Szczur (National Library of Medicine/NIH/DHHS) Chris Krahe (Aquilent Inc.) Colette Hochstein (National Library of Medicine/NIH/DHHS) Abstract The National Library of Medicine (NLM) has an extensive collection of environmental health information, including bibliographic and factual data on hazardous chemical substances in its TOXNET databases. TOXNET also provides access to the EPA Toxic Release Inventory (TRI) data, which covers air, water, and land releases, as reported by industrial facilities around the United States. Built using ArcIMS, NLM has developed a web-based system, TOXMAP, in which users can dynamically create maps that show where TRI chemicals are released and directly link to the appropriate chemical data records in TOXNET. By extracting the associated regional geographic terms from the displayed map (e.g., rivers, towns, county, state), TOXMAP (http://toxmap.nlm.nih.gov/) also provides customized chemical and/or region-specific searches to NLM's bibliographic bio-medical databases resources. This paper will focus on the design concepts, implementation strategy, challenges, and feedback from users. It will also address issues associated with data accuracy, the risk of data misinterpretation, and future directions. - 1 - Background The National Library of Medicine (NLM)1 is part of the National Institutes of Health (NIH), which is one of the organizations within the Department of Health & Human Services2. NLM is the world’s largest medical library and is a leader in the selection, acquisition, organization, and provision of medically related literature and data. Within NLM, the Specialized Information Services Division (SIS) is responsible for a collection of databases and related information on environmental health.
    [Show full text]
  • Leading History Elias A. Zerhouni, MD December 19, 2019
    Episode 16: Leading History Elias A. Zerhouni, MD December 19, 2019 American College of Radiology, through its Radiology Leadership Institute (RLI), offers this podcast as one of a series of educational discussions with radiology leaders. The podcasts reflect the perspectives of the individual leaders, not of ACR or RLI. ACR disclaims liability for any acts or omissions that occur based on these discussions. Listeners may download the transcript for their own learning and share with their colleagues in their practices and departments. However, they may not copy and redistribute any portion of the podcast content for any commercial purpose. Episode 16: Leading History Elias A. Zerhouni, MD [00:00:01.282] Geoff: This month, we have an extra special holiday treat for you. As you will soon hear, Elias Zerhouni has had profoundly broad influence both within the field of radiology and well beyond it through the establishment of national policies for the organization and prioritization of health sciences research, advising international heads of state on science and technology strategy, facilitating the global availability of vaccines, and reorganizing one of the world's largest pharmaceutical companies to pivot from small molecule discovery to the development of therapeutic biologics. Elias Zerhouni has fearlessly approached his career as a series of professional disruptions that offer a lesson to us all in taking chances and making bold decisions. [00:00:51.453] No matter where you are in your career, as you listen to Elias's story, I invite you to reflect on your own journey and the decisions that you may be facing.
    [Show full text]
  • National Library of Medicine Programs and Services FY2013
    NATIONAL INSTITUTES OF HEALTH National Library of Medicine Programs and Services Fiscal Year 2013 US Department of Health and Human Services Public Health Service Bethesda, Maryland National Library of Medicine Catalog in Publication National Library of Medicine (US) National Library of Medicine programs and services.— Bethesda, Md.: The Library, [1978-] 1977 – v.: Report covers fiscal year. Continues: National Library of Medicine (US). Programs and Services. Vols. For 1977-78 issued as DHEW publication; no. (NIH) 78-256, etc.; for 1979-80 as NIH publication; no. 80-256, etc. Vols. 1981 – present Available from the National Technical Information Service, Springfield, Va. Reports for 1997 – present issued also online. ISSN 0163-4569 = National Library of Medicine programs and services. 1. Information Services – United States – Periodicals 2. Libraries, Medical – United States – Periodicals I. Title II. Title: National Library of Medicine programs & services III. Series: DHEW publication; no. 78-256, etc. IV. Series: NIH publication; no. 80-256, etc. Z 675.M4U56an DISCRIMINATION PROHIBITED: Under provisions of applicable public laws enacted by Congress since 1964, no person in the United States shall, on the ground of race, color, national origin, sex, or handicap, be excluded from participation in, be denied the benefits of, or be subjected to discrimination under any program or activity receiving Federal financial assistance. In addition, Executive Order 11141 prohibits discrimination on the basis of age by contractors and subcontractors in the performance of Federal contracts. Therefore, the National Library of Medicine must be operated in compliance with these laws and this executive order. ii CONTENTS Preface ........................................................................................................................................................................... v Office of Health Information Programs Development .................................................................................................
    [Show full text]
  • Regulatory Tracking Summary 29 June 2018
    National Aeronautics and Space Administration Principal Center for Regulatory Risk Analysis and Communication Regulatory Tracking Summary 29 June 2018 This report summarizes regulatory items reviewed by the NASA RRAC PC and includes items with direct applicability to NASA facilities and operations, as well as items of general interest. Notes and comments by the RRAC PC are shown in italic text under “Description.” Related documents and citations, such as “83 FR 51967,” are linked to the appropriate document for quick access. Suggested follow-up actions are noted with significant items; users are advised that other follow-up actions may be appropriate for their program or facility. Members of the NASA stakeholder community who are interested in receiving regulatory updates and alerts by e-mail may self-enroll at https://lists.nasa.gov/mailman/listinfo/rrac. Previous issues of this regulatory summary and other materials are archived on the RRAC PC website at http://www.nasa.gov/offices/rrac/home/. PAGE 1 OF 17 NASA RRAC PC REGULATORY TRACKING SUMMARY 29 JUNE 2018 Contents of This Issue 1.0 U.S. Federal Regulatory Review .............................................................................................................................. 4 1.1. Federal Register Summary ............................................................................................................................ 4 1.2. Other News and Developments .................................................................................................................
    [Show full text]
  • Interview with Dr. James Wyngaarden (JW) Jennifer Midura (JM), Center for Public Genomics, Institute for Genome Sciences & Policy, Duke University December 8, 2006
    Interview with Dr. James Wyngaarden (JW) Jennifer Midura (JM), Center for Public Genomics, Institute for Genome Sciences & Policy, Duke University December 8, 2006 JM: The information I am about to give you and your response will now be recorded. My name is Jennifer Midura and I am a student at Duke University. I am in a course on the history of genomics that includes oral history. One goal is to produce a written transcript of interviews with important figures in genomics. Some of the interviews may be archived or made public through a website. I selected you as the person I would like to interview. The interview should last about 45 minutes. Your participation in this interview is strictly voluntary, and you may withdraw at any time. You do not have to answer every question asked. The information that you provide will be “on the record” and may be attributed to you. This interview is being recorded and I will take written notes during the interview. The interviews that are posted publicly will be archived as a history resource. If you prefer that the interview be used only for the course and not made public, please indicate this. One risk of this study is that you may disclose information that later could be requested for legal proceedings. Or you may say something that embarrasses you or offends someone else when they read it on a public website. The benefit of participating in this study is ensuring that your side of the story is properly portrayed in the history of genomics.
    [Show full text]
  • Tyears the News Media Have Been Awash in Storie'abljut Increasingly Close Ties Between O College Campuses and Multimillion-Dollar Corpora­ - Tions
    :,1 C/) In recentyears the news media have been awash in storie'abljut increasingly close ties between o college campuses and multimillion-dollar corpora­ - tions. Our nation's universities, the story goes, reap m enormtus windfalls patenting products of scientific z ****************** ***~1* research that have been primarily funded by taxpay­ ers. Meanwhile, hoping for new streams of revenue SC IENCE SA{E from their innovations, the same universities are o j FOR allowing their research-and their very principles­ m to become compromised by quests for profit. But "Tl is that really the case? Is money really hopelessly o corrupting science? ;0 With Science for Sale, acclaimed journalist Daniel REliI\A~RmS, S. Greenberg reveals that campus capitalism is more ,THE PER I LS, complicated-and less profitable-than media reports C/) would suggest. While universities seek out corporate ",'AND DELUS IIQti;' '" \ funding, news stories rarely note that those industry » ~US ~ dollars are dwarfed by government support and r ·tfti/... ITA!..! s.M other funds. Also, while many universities have set up m technology-transfer offices to pursue profits through patents, many of those offices have been financial **;~:*.** busts. Meanwhile, science is showing signs of provid-: **'. ,. -: . :",,":);::,:!,:::,,:/..<':-:' ', **t*.' '::,:J<;," ****** ***.'*' * ing its own solutions, as highly publicized misdeeds in pursuit of profits have provoked promising counter­ measures within the field. But just because the threat is overhyped, Greenberg argues, doesn't mean that there's no danger. From research that's shifted overseas so corporations can avoid regulations to conflicts of interest in scientific I publishing, the temptations of money will always be I a threat, and they can only be countered through the viqilance of scientists, the press, and the public.
    [Show full text]
  • National Library of Medicine 8600 Rockville Pike Bethesda, MD 20894 301-496-6308 E-Mail: [email protected] Web
    Further information about the programs described in this administrative report is available from the: Office of Communications and Public Liaison National Library of Medicine 8600 Rockville Pike Bethesda, MD 20894 301-496-6308 E-mail: [email protected] Web: www.nlm.nih.gov Cover: “Changing the Face of Medicine,” an exhibition at the NLM, honors the lives and achievements of American women in medicine NATIONAL INSTITUTES OF HEALTH NATIONAL LIBRARY OF MEDICINE PROGRAMS AND SERVICES FISCAL YEAR 2003 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE BETHESDA, MARYLAND National Library of Medicine Catalog in Publication Z National Library of Medicine (U.S.) 675.M4 National Library of Medicine programs and services.– U56an 1977- .–Bethesda, Md. : The Library, [1978- v.: ill., ports. Report covers fiscal year. Continues: National Library of Medicine (U.S.). Programs and Services. Vols. For 1977-78 issued as DHEW publication; no. (NIH) 78-256, etc.; for 1979-80 as NIH publication; no. 80-256, etc. Vols. For 1981-available from the National Technical Information Service, Springfield, Va. ISSN 0163-4569 = National Library of Medicine programs and services. 1. Information Services œ United States œ periodicals 2. Libraries, Medical œ United States œ periodicals I. Title II. Series: DHEW publication ; no. 80-256, etc. DISCRIMINATION PROHIBITED: Under provisions of applicable public laws enacted by Congress since 1964, no person in the United States shall, on the ground of race, color, national origin, sex, or handicap, be excluded from participation in, be denied the benefits of, or be subjected to discrimination under any program or activity receiving Federal financial assistance.
    [Show full text]
  • October 28, 2003, NIH Record, Vol. LV, No. 22
    R a StillThe SecondPayday BestThingAbout Hill Hearing Airs NIH Needs, Telework on the Rise Congress' Concerns By Rich McMenus Top Reasons More AreChoosing On the heels of the debut of NIH's new More NIH'ers Opt To Work Awayfrom Work To Work from Roadmap initiative and release of an Home Institute of Medicine report on the structure and vitality of NIH, a hearing was held Oct. t's not as if anyone needs added incentive to roll.out of bed a 2 at which director Dr. Elias Zerhouni ZerhouniLaunches little later, spend a few extra minutes with the family, steer reported to joint Senate and House Roadmap Initiative clear of rush-hour traffic or accomplish a day's work virtually uninterrupted.I No, the reason that committees on how closely the two visions merge as NIH faces its post-budget­ telework is growing-but still only doubling future. The directoralso heard a slowly-could be that few employees 'Director's Corner' realize the option may be available host of lawmakers' concerns, ranging from Speaks to NIH'ers A-76 to stem cells to studiesof human to them. However, as campus sexuality. parking spaces become rarer this fall, more people may be seeking-and NAS' Alberts To Zerhouni was joined at the witnesstable by more managers and supervisors Speak, Nov. 3 his predecessor, Dr. Harold Varmus, and by encouraging-ways to work away Dr. Harold Shapiro, who chaired the IOM from work. The trend is picking up committee on NIH revitalization; all three Cultural Lecture speed at NIH and throughout government.
    [Show full text]
  • Debt Ceiling Negotiations Come Down to the Wire
    PAGE 5 PAGE 6 INSERT Report: U.S. Lagging in Stem Cell Lawsuit The Role of the CDC in University R&D Dismissed Global Health R&D JULY-AUGUST 2011 ReTHEsearch ADVOCATE BRINGING RESEARCH CLOSER TO HOME Debt Ceiling Negotiations Come Down to the Wire At the time of this writing, debt ceiling tus to cut funding for health research these caps would limit the amount by negotiations between the White House and all discretionary programs has which agency budgets are able to grow. and congressional leadership have never been greater and it is up to you The National Institutes of Health stalled. Recent proposals for raising to turn the tide. budget, for example, is currently about the debt ceiling have included manda- If an agreement is reached, it could $31 billion for this fiscal year. A long- tory long-term spending cuts and result in deep cuts in funding for term spending cap would hamstring spending caps. Everyone in the health health research and long-term restric- funding for health research at NIH and research community needs to step up tions on any potential future increases other agencies. their advocacy efforts now. The impe- in discretionary spending. Ultimately, Continued on page 4 One Mind Forum Lays Out Plan the anniversary of tors and create partnerships toward the for Neuroscience Research former President goal of a greater understanding of brain John F. Kennedy’s disorders. The group hopes to raise an The One Mind for Research Forum, 1961 challenge to send a man to the additional $1.5 billion for brain held in Boston and featuring world- moon within a decade.
    [Show full text]
  • Appendix: Environmental Health Information and Resources
    HSG Guide Version 1.3 Appendix January 2016 Is a health study the answer for your community? A guide for making informed decisions For decades, environmental health scientists at Boston University School of Public Health have worked with community groups to address environmental health problems. We wrote the Health Studies Guide to assist community groups and individuals who think that some form of environmental health investigation or health study may be useful or necessary in their community. Readers of this guide may have concerns about drinking water contamination, or the relationship between emissions from a power plant and asthma in their community. People may suspect that a certain disease in their community, such as lupus, has an environmental cause or trigger. All of these are reasons for wanting a health study. Hopefully this Guide will help readers think this through. Appendix: Environmental Health Information and Resources The Guide can be found on our website at http://www.bu.edu/sph/health-studies-guide/ 1 HSG Guide Version 1.3 Appendix January 2016 Appendix: Environmental Health Information and Resources 1. Data on Exposures and Health Outcomes in your Community Toxics Release Inventory – http://www.epa.gov/tri US EPA’s Toxics Release Inventory reports the quantities of several hundred toxic chemicals released by individual industrial facilities each year; each facility is required to submit detailed information about releases, both intentional and accidental, for a large list of hazards. If you are interested in a particular facility, or in releases of a particular chemical across your region, you are likely to find it here.
    [Show full text]